MedTech Acquisition adjourns special meeting to Dec 12 to seek votes for extension to June 2023

TriSalus Life Sciences, Inc.

Special Meeting adjourned from Dec 7 to Dec 12, 2022 to solicit more votes for Extension Amendment.
Extension Amendment would push business combination deadline from Dec 22, 2022 to June 22, 2023.
Adjournment Proposal approved: 18,357,148 FOR, 4,839,932 AGAINST, 56,835 abstain.
Company is pursuing merger with TriSalus Life Sciences as previously announced on Nov 11, 2022.
Record date remains Oct 24, 2022; shareholders who already voted need not take action.

item 5.07 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TriSalus Life Sciences, Inc. shareholders approved The Adjournment Proposal at the 2022-12-07 meeting.

Outcome: passed
Meeting: 2022-12-07

Exact text from the filing

The sole proposal that was presented at the Special Meeting was the “The Adjournment Proposal”, which is a proposal allowing the MedTech board of directors to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to provide more time to seek approval of the Extension Amendment. The MedTech stockholders approved the Adjournment Proposal. The voting results were as follows: FOR AGAINST ABSTAIN 18,357,148 4,839,932 56,835

View on SEC.gov

553 shareholder votes filed in the last 30 days. Browse all shareholder votes →

TriSalus Life Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-125257

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.